The impact of your fundraising

NEW TREATMENTS  

We are now entering a new era, with two new treatments for Alzheimer’s disease on the horizon. Lecanemab and donanemab work by removing the build-up of a protein called amyloid from the brain. 

Although they only work for people with early-stage disease, and come with some significant side effects, they are the first drugs that slow the progression of the disease rather than just treating its symptoms. 

And with 141 potential drugs for Alzheimer’s disease being tested in 187 trials across the globe, we are finally gaining ground on tackling this devastating condition. 

But we need to keep going so we find newer and better treatments for all forms of dementia.  

And with researchers at our Drug Discovery Alliance working on more than 20 drug discovery projects right now, we are determined to find a cure.   

Please support us in our search for a cure. 

Drugs like lecanemab and donaemab show us what can be achieved through the power of research.  

But we need to find drugs that go beyond removing amyloid, and to find treatments for other forms of dementia, such as dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD).  

And we’re working on new ways to diagnose the disease, so that more people receive a swift, accurate and early diagnosis and can access treatments and research.  

Our research is also looking at ways to prevent dementia from happening in the first place, and revealing new clues to how we can all reduce our risk of developing it. 

It’s only through your support for our life-changing research that will end the fear, harm and heartbreak of dementia. 

Please support us to help find a cure.